Filter
2145
Featured
237
5
Language
Document type
626
306
294
243
123
116
115
111
71
53
30
29
24
3
1
Countries / Regions
239
199
183
147
133
124
104
98
91
86
85
82
80
75
73
69
67
50
48
46
44
42
42
39
37
32
30
30
29
28
27
26
25
25
25
24
24
22
22
22
21
21
20
18
18
17
17
16
16
15
15
14
14
14
14
13
12
12
12
12
11
11
11
11
10
10
10
10
10
9
9
9
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Toolboxes
1933
41
24
9
8
8
8
5
5
3
2
2
1
1
1
1
1
Prevention and Control of Covid-19 Transmission: Isolation and follow-up of suspected and/or confirmed cases and close contact tracing strategy
Position paper on vaccination with Sputnik V vaccine | National Commission on Vaccine Safety (CoNaSeVa) | 12 May 2021
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
Palliative care in COVID-19 patients - 27 January 2021
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
Natural immunity against COVID-19
Scientific report 10 May 2021
The role of community health workers in the vaccination against COVID-19: guide to support the implementation of the vaccination programme
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
Hypertension and COVID-19: Scientific report - 17 June 2021
Facilitator's Manual - Inter-action Review on the response to COVID-19 - 28 April 2021
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Guideline for the development of a national plan for the operationalization of vaccination against COVID-19
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é
...
Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet misinformation about the safety and effects of any future vaccine is already threatening its rollout. In
...
Emergency medical teams (EMTs) play an important role in strengthening health service networks in terms of their strategies and tactics for planning mass vaccination programs, especially in remote or under-resourced areas or those overwhelmed by COVID-19. EMTs experience deploying in remote areas an
...
The COVID-19 pandemic has impacted regular cardiovascular healthcare access and delivery. Service utilisation has declined, and excess cardiovascular mortality has been reported in several countries. We aim to estimate excess cardiovascular deaths in Chile during 2020.
